HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENFLEET-B

32.000

+0.7402.37%

Volume:1.61M

Turnover:52.31M

Market Cap:11.84B

PE:-16.19

High:34.280

Open:30.900

Low:30.000

Close:31.260

52wk High:50.200

52wk Low:24.320

Shares:370.00M

HK Float Shares:338.00M

Volume Ratio:1.69

T/O Rate:0.48%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.976

ROE:--

ROA:-30.27%

PB:-4.09

PE(LYR):-16.19

PS:55.90

Loading ...

Overview Company News Filings

HK Stock Movement | GENFLEET-B (02595) Surges Over 8% in Late Trading as GFH375 Tablets Enter Phase III Clinical Trial for Metastatic Pancreatic Cancer

HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 9%

Tiger Newspress

Hong Kong Stock Movement | GENFLEET-B (02595) Recovers Over 9% After Completion of First Patient Enrollment in GFH375 Combination Therapy for Advanced Solid Tumors

GenFleet (2595) Announces First Patient Dosed in Phase Ib/II Trial of GFH375 for Advanced Solid Tumors

Bulletin Express

GenFleet Therapeutics Doses First Patient in Phase Ib/II Trial of KRAS G12D Inhibitor GFH375 for Advanced Solid Tumors

GENFLEET-B (02595): First Patient Dosed in Ib/II Study of KRAS G12D Inhibitor GFH375 Combined with Cetuximab or Chemotherapy for Advanced Solid Tumors

GenFleet Inc. Releases Updated Articles of Association, Total Shares at 370,366,630

Bulletin Express

GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 2595) Updates Registered Share Capital and Amends Articles of Association

Bulletin Express

GenFleet (02595) Announces Issuance of 13,386,000 New H Shares at HKD 20.39

Bulletin Express

GENFLEET-B (02595) Issues 13.386 Million Shares on October 21 Due to Full Exercise of Over-allotment Option

GenFleet Therapeutics (Shanghai) Inc. (2595) Reveals Positive Phase I/II Data on GFH375 for KRAS G12D-Mutant PDAC

Bulletin Express

GenFleet Therapeutics Issues Nearly 13.4 Million Shares on Full Exercise of IPO Overallotment Option

MT Newswires Live

GENFLEET-B (02595) Fully Exercises Over-Allotment Option, Stabilization Period Concludes

GENFLEET-B (02595) Announces First Patient Enrollment in Phase I/II Clinical Trial of Molecular Glue Pan RAS(ON) Inhibitor GFH276 for RAS-Mutant Cancer Treatment

Stock Track | GENFLEET-B Soars 10.92% Following Major Share Transfer and Recent Successful IPO

GENFLEET-B (02595) Shareholder Transfers Shares from CITIC Securities Brokerage Hong Kong to Standard Chartered Bank (Hong Kong) with Transfer Value of HK$437 Million

GENFLEET-B (02595) Becomes New Favorite in Innovative Drug Bull Market Despite 6%+ Drop on Second Trading Day

Hong Kong Stocks End Flat Ahead of Trump-Xi Call; GenFleet Therapeutics Posts Stellar Debut

MT Newswires Live

GenFleet Therapeutics Soars 116% in Hong Kong Debut

MT Newswires Live

Stock Track | GenFleet Therapeutics Skyrockets 115.60% in Hong Kong Debut, Fueled by Strong IPO Demand

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02595/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":32,"timestamp":1763107689798,"preClose":31.26,"halted":0,"volume":1605662,"delay":0,"floatShares":338000000,"shares":370000000,"eps":-1.976,"marketStatus":"Closed","change":0.74,"latestTime":"11-14 16:08:09","open":30.9,"high":34.28,"low":30,"amount":52311711,"amplitude":0.136916,"askPrice":32.26,"askSize":5400,"bidPrice":32,"bidSize":4200,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":5,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":31.26,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.68923,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":338000000,"roa":"-30.27%","roe":"--","lyrEps":-1.976,"volumeRatio":1.68923,"shares":370000000,"dividePrice":0,"high":34.28,"amplitude":0.136916,"preClose":31.26,"low":30,"week52Low":24.32,"pbRate":"-4.09","psRate":"55.90","week52High":50.2,"institutionHeld":0,"latestPrice":32,"committee":-0.125,"eps":-1.976,"divideRate":0,"volume":1605662,"delay":0,"ttmEps":-2.744,"open":30.9,"prevYearClose":20.39,"prevWeekClose":27,"prevMonthClose":27.32,"prevQuarterClose":40,"fiveDayClose":27,"twentyDayClose":31.2,"sixtyDayClose":20.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2025-11-13","current":-11.661808,"percent":0.416667,"low":-19.62221,"twenty":-18.598566,"median":-10.699818,"eighty":-9.918285,"high":-9.058573,"avg":-12.993309,"sd":3.872885,"marketCap":11577660853},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-13","current":-11.404855,"twenty":-18.598566,"median":-10.699818,"eighty":-9.918285,"marketCap":11577660853}],"updateTime":1763109225854},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192830237","title":"HK Stock Movement | GENFLEET-B (02595) Surges Over 8% in Late Trading as GFH375 Tablets Enter Phase III Clinical Trial for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1192830237","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192830237?lang=en_us&edition=fundamental","pubTime":"2025-11-13 15:58","pubTimestamp":1763020694,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) rose more than 8% in late trading, closing up 7.46% at HK$31.1 with a turnover of HK$28.08 million. On November 11, the drug clinical trial registration platform revealed that...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","02595","BK1161","BK4134","159938","III","BK1574"],"gpt_icon":0},{"id":"1167719428","title":"HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167719428","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167719428?lang=en_us&edition=fundamental","pubTime":"2025-11-10 14:11","pubTimestamp":1762755100,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong this afternoon. Ascletis Pharma rose 9% ; Sirnaomics rose 8%; Innogen, Kintor Pharmaceutical, and GenFleet rose 6%; Duality Biotherapeutics rose 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"afa821d7c5aabc22fa508f3ca44a801f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09606","02591","09939","01672","02257"],"gpt_icon":0},{"id":"1163588999","title":"Hong Kong Stock Movement | GENFLEET-B (02595) Recovers Over 9% After Completion of First Patient Enrollment in GFH375 Combination Therapy for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1163588999","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163588999?lang=en_us&edition=fundamental","pubTime":"2025-10-23 15:20","pubTimestamp":1761204032,"startTime":"0","endTime":"0","summary":"According to reports, GENFLEET-B (02595) experienced a drop of over 8% in the afternoon, but rebounded to increase by more than 9% near the market close. As of the time of reporting, the stock rose...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","159938","09939","BK1161","02595"],"gpt_icon":0},{"id":"1168205588","title":"GenFleet (2595) Announces First Patient Dosed in Phase Ib/II Trial of GFH375 for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1168205588","media":"Bulletin Express","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168205588?lang=en_us&edition=fundamental","pubTime":"2025-10-22 07:42","pubTimestamp":1761090127,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GenFleet, stock code: 2595) announced that the first patient has been dosed in a Phase Ib/II trial of GFH375, an oral KRAS G12D (ON/OFF) inhibitor, combined...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2577386108","title":"GenFleet Therapeutics Doses First Patient in Phase Ib/II Trial of KRAS G12D Inhibitor GFH375 for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2577386108","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577386108?lang=en_us&edition=fundamental","pubTime":"2025-10-22 07:36","pubTimestamp":1761089794,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics  Inc. announced that the first patient has been dosed in a phase Ib/II clinical trial investigating GFH375, an oral KRAS G12D  inhibitor, in combination with cetuximab or chemotherapy for patients with advanced solid tumors, including first-line pancreatic ductal adenocarcinoma . The clinical trial application for GFH375 was approved by China's National Medical Products Administration . At this time, no trial results have been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics  Inc. published the original content used to generate this news brief on October 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL9r9NM0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161"],"gpt_icon":0},{"id":"1107273031","title":"GENFLEET-B (02595): First Patient Dosed in Ib/II Study of KRAS G12D Inhibitor GFH375 Combined with Cetuximab or Chemotherapy for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1107273031","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107273031?lang=en_us&edition=fundamental","pubTime":"2025-10-22 07:36","pubTimestamp":1761089773,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that the first patient has been dosed in the Ib/II study of GFH375, a KRAS G12D inhibitor, in combination with therapies targeting advanced solid tumors with KRAS G12D...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","159938","BK1574","02595","09939"],"gpt_icon":0},{"id":"1118241793","title":"GenFleet Inc. Releases Updated Articles of Association, Total Shares at 370,366,630","url":"https://stock-news.laohu8.com/highlight/detail?id=1118241793","media":"Bulletin Express","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118241793?lang=en_us&edition=fundamental","pubTime":"2025-10-21 22:21","pubTimestamp":1761056516,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (hereinafter referred to as GenFleet Inc.) has officially released an updated version of its Articles of Association, effective October 21, 2025. The document...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1192884997","title":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 2595) Updates Registered Share Capital and Amends Articles of Association","url":"https://stock-news.laohu8.com/highlight/detail?id=1192884997","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192884997?lang=en_us&edition=fundamental","pubTime":"2025-10-21 22:01","pubTimestamp":1761055293,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 2595) announced that following the full exercise of the Over-allotment Option—resulting in the issuance of 13,386,000 H shares—its registered share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1105722511","title":"GenFleet (02595) Announces Issuance of 13,386,000 New H Shares at HKD 20.39","url":"https://stock-news.laohu8.com/highlight/detail?id=1105722511","media":"Bulletin Express","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105722511?lang=en_us&edition=fundamental","pubTime":"2025-10-21 16:43","pubTimestamp":1761036238,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (the “Company”) announced an issuance and allotment of 13,386,000 new H shares on 21 October 2025 upon the full exercise of an over-allotment option. The shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"1160128853","title":"GENFLEET-B (02595) Issues 13.386 Million Shares on October 21 Due to Full Exercise of Over-allotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=1160128853","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160128853?lang=en_us&edition=fundamental","pubTime":"2025-10-21 16:36","pubTimestamp":1761035778,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on October 21, 2025, it issued and distributed 13.386 million H-shares due to the full exercise of the over-allotment option.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","02595","09939","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"1120429508","title":"GenFleet Therapeutics (Shanghai) Inc. (2595) Reveals Positive Phase I/II Data on GFH375 for KRAS G12D-Mutant PDAC","url":"https://stock-news.laohu8.com/highlight/detail?id=1120429508","media":"Bulletin Express","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120429508?lang=en_us&edition=fundamental","pubTime":"2025-10-20 08:21","pubTimestamp":1760919692,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 2595) presented phase I/II data on its oral KRAS G12D (ON/OFF) inhibitor, GFH375, in pancreatic ductal adenocarcinoma (PDAC) at the ESMO Congress...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2576160700","title":"GenFleet Therapeutics Issues Nearly 13.4 Million Shares on Full Exercise of IPO Overallotment Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2576160700","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576160700?lang=en_us&edition=fundamental","pubTime":"2025-10-17 13:19","pubTimestamp":1760678359,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics   said the overallotment option from its Hong Kong IPO has been fully exercised, resulting in the issue of nearly 13.4 million H shares at HK$20.39 each, according to a Thursday bourse filing.Shares of the firm rose nearly 4% in midday trading on Friday.The additional shares, representing about 15% of the total offer size, will generate net proceeds of roughly HK$260.6 million after expenses.The funds will be used on a pro rata basis for purposes previously disclosed in its prospectus, the filing said.After the full exercise, the company's public float increased to 73%, above the minimum requirement under HKEX rules.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02595","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"1111166937","title":"GENFLEET-B (02595) Fully Exercises Over-Allotment Option, Stabilization Period Concludes","url":"https://stock-news.laohu8.com/highlight/detail?id=1111166937","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111166937?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:08","pubTimestamp":1760616510,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that its sole sponsor and overall coordinator, acting on behalf of itself and the international underwriters, has fully exercised the over-allotment option as described...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","159938","02595","BK1574","09939"],"gpt_icon":0},{"id":"1170330142","title":"GENFLEET-B (02595) Announces First Patient Enrollment in Phase I/II Clinical Trial of Molecular Glue Pan RAS(ON) Inhibitor GFH276 for RAS-Mutant Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1170330142","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170330142?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:46","pubTimestamp":1759149968,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that the first patient has been enrolled in the Phase I/II clinical trial of GFH276 for treating RAS-mutant advanced solid tumors. The National Medical Products...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357305700.SGD","LU0124384867.USD","LU2360107325.USD","BK1161","LU1720051108.HKD","BK4585","LU1861220033.SGD","ON","LU2298322129.HKD","LU1978683503.SGD","LU1548497426.USD","LU1861215975.USD","LU1861219969.SGD","IE00BD6J9T35.USD","BK1574","LU1861214812.USD","02595","BK4588","BK4605","159938","09939","LU0348723411.USD","LU0724618433.USD","BK4141","BK4512","IE00BZ199S13.USD","LU1720051017.SGD","LU1854103824.USD","LU1854104046.USD","BK1515"],"gpt_icon":1},{"id":"1101926128","title":"Stock Track | GENFLEET-B Soars 10.92% Following Major Share Transfer and Recent Successful IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1101926128","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101926128?lang=en_us&edition=fundamental","pubTime":"2025-09-24 10:34","pubTimestamp":1758681281,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595), a newly listed biotech company on the Hong Kong Stock Exchange, saw its shares soar by 10.92% in Wednesday's trading session. This significant uptick comes on the heels of a major...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02595"],"gpt_icon":1},{"id":"1165222921","title":"GENFLEET-B (02595) Shareholder Transfers Shares from CITIC Securities Brokerage Hong Kong to Standard Chartered Bank (Hong Kong) with Transfer Value of HK$437 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1165222921","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165222921?lang=en_us&edition=fundamental","pubTime":"2025-09-24 08:28","pubTimestamp":1758673701,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 23rd, a shareholder of GENFLEET-B (02595) transferred shares from CITIC Securities Brokerage Hong Kong to Standard...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997244956.HKD","LU1794554557.SGD","BK1161","BK0196","LU1997245094.SGD","BK0276","LU1997245177.USD","LU0405327494.USD","BK0183","BK1516","LU1064130708.USD","600030","LU2289578879.USD","BK1521","BK1147","LU2148510915.USD","BK0012","LU1255011170.USD","BK1564","LU1064131003.USD","LU2495084118.USD","BK1574","02595","159938","LU1655091616.SGD","09939","BK0028","LU0405327148.USD","LU1720050803.USD","BK0188","LU1328615791.USD","06030","BK1515"],"gpt_icon":1},{"id":"1180347436","title":"GENFLEET-B (02595) Becomes New Favorite in Innovative Drug Bull Market Despite 6%+ Drop on Second Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1180347436","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180347436?lang=en_us&edition=fundamental","pubTime":"2025-09-22 19:35","pubTimestamp":1758540910,"startTime":"0","endTime":"0","summary":"On September 19, GENFLEET-B (02595) made its debut on the Hong Kong Stock Exchange, with its share price reaching an intraday high of HK$50.20, representing a 146.20% increase from the issue price,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","09939","BK1574","BK1161","06978","02595","159992","BK1515"],"gpt_icon":1},{"id":"2568779255","title":"Hong Kong Stocks End Flat Ahead of Trump-Xi Call; GenFleet Therapeutics Posts Stellar Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2568779255","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568779255?lang=en_us&edition=fundamental","pubTime":"2025-09-19 16:42","pubTimestamp":1758271330,"startTime":"0","endTime":"0","summary":"Hong Kong stocks ended flat on Friday as investors closely watched the outcome of the talk between US President Donald Trump and Chinese counterpart Xi Jinping.The Hang Seng Index finished little changed at 26,545.10, while the Hang Seng China Enterprises Index  barely moved in positive territory to close at 9,472.35.Trump and Xi are expected to hold their first known call in three months on Friday, with a potential agreement to keep TikTok operating in the United States high on the agenda alongside trade talks.The US president told Fox News on Thursday it seemed Beijing had approved a deal on the short-video app, Reuters reported.In corporate news, GenFleet Therapeutics  debuted in Hong Kong and closed about 106% higher at HK$42.10, compared with its offer price of HK$20.39.China Properties Investment  gained over 4% after announcing a potential fundraising to strengthen its financial position and provide additional working capital.Meanwhile, Zijin Gold International  launched its ini","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"96f118e6e5ea0809da2a2d2a9b3c5202","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","MHImain","HSCEI","02595","BK4539","HSI","BK4139","02259","MCHmain","HHImain","02833","BK4007","513600"],"gpt_icon":1},{"id":"2568385832","title":"GenFleet Therapeutics Soars 116% in Hong Kong Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2568385832","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568385832?lang=en_us&edition=fundamental","pubTime":"2025-09-19 09:42","pubTimestamp":1758246177,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (HKG:2595) shares surged 115.8% above the IPO price in its Hong Kong debut on Friday morning.The biopharmaceutical firm opened at HK$44.00 per share, compared with the IPO price of HK$20.39.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02595","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"1150292311","title":"Stock Track | GenFleet Therapeutics Skyrockets 115.60% in Hong Kong Debut, Fueled by Strong IPO Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1150292311","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150292311?lang=en_us&edition=fundamental","pubTime":"2025-09-19 09:32","pubTimestamp":1758245575,"startTime":"0","endTime":"0","summary":"Shares of GenFleet Therapeutics (02595.HK) soared an impressive 115.60% in their Hong Kong stock market debut on Friday, reflecting robust investor enthusiasm for the biopharmaceutical company. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4237ebd7fb3543d94bf340da7a4d9b8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02595"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}